Japan Ahead: Olympus COO Abia on Strategy, Outlook

The transcript discusses Olympus' strategic shift towards medical devices, divestment of its science business, and focus on mergers and acquisitions in therapeutics. It outlines financial goals, product innovation, and governance reforms post-scandal. The challenges of globalization and economic growth in Japan are addressed, along with supply chain issues and market adaptation strategies.

What is the company's strategy regarding mergers and acquisitions?

What changes have been made in Olympus's governance since the accounting scandal?

How does Olympus plan to adapt to the uncertain global market conditions?